关注
Vivienne C. Bachelet
Vivienne C. Bachelet
Associate professor, School of Medicine, University of Santiago of Chile
在 usach.cl 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Do we know the diagnostic properties of the tests used in COVID-19? A rapid review of recently published literature
VC Bachelet
Medwave 20 (3), 2020
42*2020
A systematic review of the effectiveness of interventions to reduce motor vehicle crashes and their injuries among the general and working populations
Á Lefio, VC Bachelet, R Jiménez-Paneque, P Gomolán, K Rivas
Revista panamericana de salud publica 42, e60, 2018
392018
Policy strategies to reduce waiting times for elective surgery: a scoping review and evidence synthesis
VC Bachelet, M Goyenechea, VA Carrasco
The International journal of health planning and management 34 (2), e995-e1015, 2019
332019
Violence and burnout in health care emergency workers in Santiago, Chile: A survey-based cross-sectional study
RE Jiménez, VC Bachelet, P Gomolán, LÁ Lefio, M Goyenechea
International emergency nursing 47, 100792, 2019
302019
Sex and gender analysis for better science and health equity
S Heidari, VC Bachelet
The Lancet 392 (10157), 1500-1502, 2018
292018
Author misrepresentation of institutional affiliations: protocol for an exploratory case study
VC Bachelet, FA Uribe, RA Díaz, AF Vergara, F Bravo-Córdova, ...
BMJ open 9 (2), e023983, 2019
172019
Quality of reporting and risk of bias of randomized clinical trials published in Spanish and Latin American journals
VC Bachelet, H Pardo-Hernandez
Medwave 19 (01), 2019
17*2019
Work-related injuries resulting in death in Chile: a cross-sectional study on 2014 and 2015 registries
VC Bachelet
BMJ open 8 (6), e020393, 2018
162018
Why the Helsinki Declaration now encourages trial registration, and publication and dissemination of the results of research
VC Bachelet, G Rada
Medwave 13 (10), e5846, 2013
14*2013
A tale of harm, waste and deception: how big pharma has undermined public faith in trial data disclosure and what we can do about it
VC Bachelet
Medwave 13 (4), e5671, 2013
142013
Missing clinical trial data, but also missing publicly-funded health studies
VC Bachelet
Medwave 13 (06), e5740, 2013
132013
¿ Conocemos las propiedades diagnósticas de las pruebas usadas en COVID-19? Una revisión rápida de la literatura recientemente publicada. Rev Medwave. 2020 [citado 29/05/2020 …
VC Bachelet
102020
Smoking and obesity in Chile's Third National Health Survey: light and shade
VC Bachelet, F Lanas
Revista Panamericana de Salud Pública 42, e132, 2018
102018
The Tamiflu saga continues: will our conduct change after the publication of the latest systematic review on benefits and harms of oseltamivir?
VC Bachelet
Medwave 14 (04), 2014
102014
Advancing women in science, medicine and global health: on the# LancetWomen special issue
VC Bachelet
Medwave 19 (2), e7598, 2019
92019
Hospital concessions in Chile: where we are and where we are heading
VC Bachelet
Medwave 14 (10), 2014
9*2014
Inequality in health–OECD statistics for Chile
VC Bachelet
Medwave 11 (09), e5128, 2011
82011
Respondent-driven sampling: Advantages and disadvantages from a sampling method
MS Navarrete, C Adrian, VC Bachelet
Medwave 21 (01), 2022
72022
Misrepresentation of institutional affiliations: The results from an exploratory case study of Chilean authors
VC Bachelet, FA Uribe, RA Díaz, AF Vergara, F Bravo‐Córdova, ...
Learned Publishing 32 (4), 335-344, 2019
72019
SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol
VC Bachelet, I Silva-Ayarza, FJ Lizana, P Gomolán, D Silva-Villalobos, ...
BMJ open 12 (5), e061345, 2022
62022
系统目前无法执行此操作,请稍后再试。
文章 1–20